Ketamine for Post-Traumatic Stress Disorder (PTSD)

 

Ketamine for Post-Traumatic Stress Disorder(PTSD) Summary

Research into Ketamine for PTSD focuses on its ability to rapidly disrupt traumatic memory cycles and its synergy with specialized psychotherapy. A 2025 study found that most significant symptoms reductions occur early, during the first 3 treatments. Another 2025 study found that repeated infusions of Ketamine achieved a 67-80% response rate for chronic PTSD. A 2024 study found that Ketamine-Assisted Psychotherapy results sustained for up to 6 months after the final session.

Note: Ketamine has not yet officially been approved for treating PTSD by the FDA, so its use is considered "off-label" and should only be done under supervision of a physician.

1) Mechanism of Action

Ketamine has been investigated as a rapid-acting treatment for PTSD, especially in individuals with treatment-resistant symptoms.

  • NMDA receptor antagonism affects glutamatergic signaling
  • Increased AMPA receptor activity
  • Activation of BDNF and mTOR pathways
  • Enhanced synaptic plasticity and neurocircuit remodeling

These effects improve dysfunction in the prefrontal cortex, amygdala, and hippocampus, helping reduce hyperarousal, intrusive memories, and maladaptive fear responses.

2) Clinical Indications

  • Treatment-resistant PTSD
  • PTSD with comorbid major depression
  • Severe PTSD with significant functional impairment

3) Clinical Effects

  • Reduced intrusive memories
  • Reduced hyperarousal
  • Decreased avoidance behaviors
  • Improved mood and emotional regulation
  • Timeline: Noticeable Results - within hours, Peak Results - several days, Total Duration 1-2 weeks for most
  • Note: Since effects are often temporary, protocols involve repeated dosing sessions.

4) Methods of Administration

Ketamine for PTSD is usually administered in specialized clinical settings.

  • Intravenous ketamine infusion
  • Intranasal ketamine or esketamine
  • Oral or sublingual ketamine in some experimental programs

Treatment is often combined with trauma-focused psychotherapy and ongoing psychiatric care.

5) Potential Advantages

  • Rapid symptom relief
  • Possible benefit for treatment-resistant patients
  • Enhances responsiveness to psychotherapy

6) Limitations and Risks

  • Short duration of benefit
  • Optimal treatment protocols remain unclear
  • Potential risk of misuse or dependence
  • Usually provided under strict medical supervision with clear risk mitigation

7) Adverse Effects

Common acute adverse effects(often resolving within 1-2 hours):

  • Dissociation
  • Perceptual disturbances
  • Dizziness
  • Nausea
  • Sedation
  • Transient increases in blood pressure

8) Current Clinical Role

Ketamine is typically considered for:

  • Severe treatment-resistant PTSD
  • Failure of trauma-focused psychotherapy
  • Failure of SSRIs/SNRIs

Care is usually delivered through specialized psychiatric programs or ketamine clinics.